Notice of Special Interest (NOSI): Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (SBIR/STTR)

Funding Agency:
National Institutes of Health

The National Center for Complementary and Integrative Health (NCCIH) is committed to the rigorous investigation of mind and body interventions (MBIs) to determine their usefulness and safety. Through this Notice of Special Interest (NOSI), NCCIH supports cutting-edge Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications from small business concerns that will develop and/or validate devices or electronic systems that can: 1) monitor biologically or behaviorally based processes applicable to MBIs or 2) be used in optimizing the practice or increasing the efficacy of MBIs. The applications should: 1) lead to the development of new technologies, 2) adapt existing innovative technologies, devices, and/or electronic systems, 3) repurpose existing devices and electronic systems, or 4) conduct testing of single or combined components of an integrated, long-term, automated, wearable stimulation device or electronic system to monitor or enhance the mechanistic processes or functional outcomes of MBIs. For the purposes of this NOSI, MBIs are nonpharmacologic approaches that include mind/brain focused interventions (e.g., meditation, mindfulness, hypnosis, art/music) or combined mind and body treatment (e.g., acupuncture, massage, spinal manipulation/mobilization) or meditative movement practices (e.g., yoga, tai chi, qi gong).

This notice applies to due dates on or after January 05, 2021 and subsequent receipt dates through January 05, 2024. 



Agency Website

Eligibility Requirements

Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity. 

Amount Description

According to statutory guidelines, total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards.

According to statutory guidelines, award periods normally may not exceed 1 year for Phase I and 2 years for Phase II. Applicants are encouraged to propose a project duration period that is reasonable and appropriate for completion of the research project.

Funding Type





Engineering and Physical Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

January 5, 2024